Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026)

Insmed has reported Change in Acquisitions & Divestments for 8 years, with the latest figure at $430.0 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 15.35% year-over-year to $430.0 million in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 18.51% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 106.69% from the prior year.
• Change in Acquisitions & Divestments was $430.0 million for Q2 2026 at Insmed, up from $284.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $721.0 million in Q1 2025, with the low at $10.0 million in Q3 2023.
• Average Change in Acquisitions & Divestments over 5 years is $305.7 million, with a median of $300.0 million recorded in 2023.
• The largest YoY upside for Change in Acquisitions & Divestments was 1100.0% in 2023 against a maximum downside of 80.0% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $25.0 million in 2022, then surged by 1100.0% to $300.0 million in 2023, then jumped by 138.67% to $716.0 million in 2024, then slumped by 37.71% to $446.0 million in 2025, then fell by 3.59% to $430.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $430.0 million (Q2 2026), $284.0 million (Q1 2026), and $446.0 million (Q4 2025), per Business Quant data.